Image

ctDNA Assay in Patients With Resectable Pancreatic Cancer

Investigational Study of ctDNA in Resectable Pancreatic Cancer

Recruiting
18-99 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

The purpose of this study is to determine the proportion of positive ctDNA in patients with pancreatic cancer. This study investigates the relationship between ctDNA biomarkers and patient survival.

This study evaluates the role of serial ctDNA analysis as a biomarker in patients undergoing treatment for resectable pancreatic cancer. It looks at ctDNA's potential in predicting patient outcomes.

  • Who can participate: Adults aged 18 and older with newly diagnosed resectable or borderline resectable pancreatic cancer may participate. Candidates must have a life expectancy of at least 6 months and be able to provide informed consent.
  • Study details: Participants will undergo regular treatment for pancreatic cancer, which may include chemotherapy, chemo-radiation, and surgery. Blood samples will be collected for ctDNA detection. A placebo is not used in this study.
Print
Study details
    Pancreas Cancer

NCT05052671

University of Oklahoma

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.